Breast cancer after multiple myeloma treatment

Basit Öğe Kaydı
dc.authoridgülmez, ahmet/0000-0002-3353-344X
dc.authorwosidgülmez, ahmet/ABI-8218-2020
dc.contributor.authorGulmez, Ahmet
dc.date.accessioned2024-08-04T20:45:42Z
dc.date.available2024-08-04T20:45:42Z
dc.date.issued2019
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBreast cancer is the most common cancer in women. In addition, it is the second leading cause of death after lung cancer.(1,2) The prevalence of epidemiological studies in previous studies is 22%-26%. The risk of mortality due to breast cancer is around 18%.(3,4) Multiple myeloma (MM) is a malignant disease of differentiated plasma cells. It is also the most common hematological neoplasm after lymphoma. Thirty five percent of MM patients are under the age of 65, 28% are between 65 and 74 of age and 37% are over the age of 75.(5) Pathophysiological mechanisms of MM include abnormal plasma cells (myeloma cells) occupying bone marrow, producing monoclonal immunoglobulin (M protein, M-component, and paraprotein) and increased bone destruction.(6) Breast cancer cases diagnosed concurrently with myeloma have been reported in previous case reports. There is also a patient diagnosed with myeloma following breast cancer chemotherapy. In our case, the patient was first diagnosed with MM. And then autologous bone marrow transplantation was performed following 3 cycles of chemotherapy. This presentation is unique, because in literature there is no breast cancer case after myeloma in literature review. (C) 2019 Elsevier Inc. All rights reserved.en_US
dc.identifier.doi10.1016/j.currproblcancer.2019.01.004
dc.identifier.issn0147-0272
dc.identifier.issn1535-6345
dc.identifier.issue6en_US
dc.identifier.pmid30738577en_US
dc.identifier.scopus2-s2.0-85061067465en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.urihttps://doi.org/10.1016/j.currproblcancer.2019.01.004
dc.identifier.urihttps://hdl.handle.net/11616/98640
dc.identifier.volume43en_US
dc.identifier.wosWOS:000500833200007en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherMosby-Elsevieren_US
dc.relation.ispartofCurrent Problems in Canceren_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBreast canceren_US
dc.subjectMultiple myelomaen_US
dc.subjectChemotherapyen_US
dc.titleBreast cancer after multiple myeloma treatmenten_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu